scispace - formally typeset
C

Cornel Iancu

Researcher at Iuliu Hațieganu University of Medicine and Pharmacy

Publications -  135
Citations -  2735

Cornel Iancu is an academic researcher from Iuliu Hațieganu University of Medicine and Pharmacy. The author has contributed to research in topics: Cancer & Survival rate. The author has an hindex of 25, co-authored 131 publications receiving 2233 citations. Previous affiliations of Cornel Iancu include Yahoo!.

Papers
More filters
Journal ArticleDOI

Quantum dots in imaging, drug delivery and sensor applications.

TL;DR: This review summarizes the latest developments available in literature regarding the use of QDs for medical applications and indicates an increasing interest in the development of nano-theranostics platforms for simultaneous sensing, imaging and therapy.
Journal ArticleDOI

Laparoscopic cholecystectomy: incidents and complications. A retrospective analysis of 9542 consecutive laparoscopic operations

TL;DR: Most of the postoperative incidents (except bile duct injuries) were solved by laparoscopic means, and among patients with postoperative complications 28.9% required revisional surgery.
Journal ArticleDOI

Development of nanoparticle-based optical sensors for pathogenic bacterial detection

TL;DR: The focus of this review is on the current nanoparticle-based techniques for pathogenic bacterial identification and detection using nanostructures using these applications.
Journal ArticleDOI

Carbon nanotubes as anti-bacterial agents

TL;DR: This new family of nanovectors for therapeutic delivery proved to be innovative and efficient for the transport and cellular translocation of therapeutic molecules.
Journal ArticleDOI

Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines

TL;DR: A strong interaction between the nanomaterials used in this study and the protein structure of the cells allowed a more effective action of the apoptotic agents, which could be the foundation of a new class of cancer therapies that are composed of both chemotherapeutic agents and nanommaterials.